Recurrent or Refractory B Lymphoblastic Lymphoma AALL1621

A Randomized Double-Blinded Trial of Xylitol Dental Wipes for the Prophylaxis of Bloodstream Infections From Oral Organisms in Pediatric Patients With Acute Myeloid Leukemia

Status: Open to Enrollment

A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse.

Status: Open to Enrollment

A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLyLy

Status: Open to Enrollment

The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study

Status: Open to Enrollment

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

Status: Open to Enrollment